Evidence map›Paper›PMID 35511089›Full record

ArticleThe Journal of cell biology2022

V-ATPase is a universal regulator of LC3-associated phagocytosis and non-canonical autophagy.

Kirsty M Hooper, Elise Jacquin, Taoyingnan Li, Jonathan M Goodwin, John H Brumell, Joanne Durgan, Oliver Florey

Open access · hybridAbstract read
In one paragraph

Article in The Journal of cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed
24.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 165 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Autophagy · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Full length TECPR1 displays 'cis' Dysferlin domain architecture.bioRxiv : the preprint server for biology · 2026
    Article
  17. Crosstalk between protein lipidation and ubiquitination in tumor biology.Apoptosis : an international journal on programmed cell death · 2026
    Review
  18. Review
  19. Review
  20. Review

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 4 countries.

Kirsty M HooperSignalling Programme, Babraham Institute, Cambridge, UK.
Elise JacquinSignalling Programme, Babraham Institute, Cambridge, UK.
Taoyingnan LiDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Jonathan M GoodwinCasma Therapeutics, Cambridge, MA.ORCID 0000-0003-1593-5098
John H BrumellDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-5802-7789
Joanne DurganSignalling Programme, Babraham Institute, Cambridge, UK.ORCID 0000-0002-1794-8290
Oliver FloreySignalling Programme, Babraham Institute, Cambridge, UK.ORCID 0000-0002-1075-7424
Babraham Institute · GBUniversity of Toronto · CACasma Therapeutics (United States) · US

Funding

Biotechnology and Biological Sciences Research Council BB/P013384/1Biotechnology and Biological Sciences Research Council BB/R019258/1Biotechnology and Biological Sciences Research Council BBS/E/B/000C0432Cancer Research UK C47718/A16337CIHR FDN#154329
6 · The paper itself

Abstract

Non-canonical autophagy is a key cellular pathway in immunity, cancer, and neurodegeneration, characterized by conjugation of ATG8 to endolysosomal single membranes (CASM). CASM is activated by engulfment (endocytosis, phagocytosis), agonists (STING, TRPML1), and infection (influenza), dependent on K490 in the ATG16L1 WD40-domain. However, factors associated with non-canonical ATG16L1 recruitment and CASM induction remain unknown. Here, using pharmacological inhibitors, we investigate a role for V-ATPase during non-canonical autophagy. We report that increased V0-V1 engagement is associated with, and sufficient for, CASM activation. Upon V0-V1 binding, V-ATPase recruits ATG16L1, via K490, during LC3-associated phagocytosis (LAP), STING- and drug-induced CASM, indicating a common mechanism. Furthermore, during LAP, key molecular players, including NADPH oxidase/ROS, converge on V-ATPase. Finally, we show that LAP is sensitive to Salmonella SopF, which disrupts the V-ATPase-ATG16L1 axis and provide evidence that CASM contributes to the Salmonella host response. Together, these data identify V-ATPase as a universal regulator of CASM and indicate that SopF evolved in part to evade non-canonical autophagy.

Indexed as

AutophagyAutophagy-Related ProteinsMicrotubule-Associated ProteinsPhagocytosisVacuolar Proton-Translocating ATPasesCell LineHumansATG16L1 protein, humanAutophagy-Related ProteinsMAP1LC3A protein, humanMicrotubule-Associated ProteinsVacuolar Proton-Translocating ATPases

Identifiers

PMID35511089
PMCPMC9082624
OpenAlexW4229024039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.